Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. - Wikidata - wikimedia - TriplyDB

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

http://www.wikidata.org/entity/Q35313033

about

Lumican: a new inhibitor of matrix metalloproteinase-14 activity MMP regulation of corneal keratocyte motility and mechanics in 3-D collagen matrices.Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.Membrane-associated matrix proteolysis and heart failure.A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke.Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.Membrane-Type 1 Matrix Metalloproteinase Downregulates Fibroblast Growth Factor-2 Binding to the Cell Surface and Intracellular Signaling.CTR1 silencing inhibits angiogenesis by limiting copper entry into endothelial cells.The overexpression membrane type 1 matrix metalloproteinase is associated with the progression and prognosis in breast cancer.Rapid lead discovery through iterative screening of one bead one compound libraries.Repurposing the antipsychotic trifluoperazine as an antimetastasis agent.Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14.Matrix metalloproteinases as breast cancer drivers and therapeutic targets.Identification of highly selective MMP-14 inhibitory Fabs by deep sequencing.The history of matrix metalloproteinases: milestones, myths, and misperceptions.Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail.Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo Bilayer Membrane Modulation of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Structure and Proteolytic Activity.Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression.Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression.Significance of semaphorin-3A and MMP-14 protein expression in non-small cell lung cancer.Expression and clinical significance of colorectal cancer stem cell marker EpCAM(high)/CD44(+) in colorectal cancer.PI3K in cancer-stroma interactions: bad in seed and ugly in soil.Barriers to drug delivery in solid tumors.MT1-MMP is not a good prognosticator of cancer survival: evidence from 11 studies.Matrix metalloproteinase collagenolysis in health and disease.MMP-14 in skeletal muscle repair.Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor.Matrix metalloproteinases: new directions toward inhibition in the fight against cancers.Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study.Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.

P2860

Q24305431-0EB4D27C-67AD-4EE2-B970-E2A5E081DBAD Q30578498-9EDC8ABD-15D9-4B3A-A70F-63EB702F71A0 Q30824578-2F520C6B-3689-4968-B303-FC2F710A1873 Q30843748-EE577B21-B739-4BC0-88D8-9DB035434DFF Q33632033-1C65A5DF-E27C-4C55-9159-1F8D045BCFBE Q34075901-506D0262-D500-46E9-AF64-FBB7262DAA24 Q34190659-2AA288F6-938C-40C7-BB1D-E9233390E607 Q34516000-AF2038BC-6A4A-42B8-B39E-242BDB679AF6 Q34645532-F7E041CC-DBC8-43E5-991E-01B8EB70DC10 Q34799472-F03B161E-A961-4634-87E9-517A9FFEB456 Q34988260-8EB91C96-B579-46F0-B3B2-D4B100EC918B Q35137808-6696ADEA-BE65-4FEA-B5A2-82D9F61C3252 Q35461662-4A17DB3D-8BED-4132-B04B-B7E0BB2D95CF Q35536672-E0D269C2-A5F1-41F6-84DB-5A397FEDAD3A Q35588436-9C3164D2-4906-41AB-A152-82890D41DE03 Q35760031-08A002EB-9658-4AA0-A18A-A4DC54006D0A Q35773980-EC281D18-BD39-4E1B-A109-B60847FAFC23 Q35811902-9B6D2F1A-4E97-42F0-8B05-FB2CB83A043B Q35892721-BDD060ED-D135-4B31-9128-F2BD50A4FBD3 Q36250325-3F4480E2-EEC4-4CCD-AA26-B1E46AE9F29A Q36312509-5E8783F1-1151-40A8-8C38-A976D855C32F Q36324618-41F22FDB-079A-4AA6-AAF2-B93D7DEB1BD3 Q36349912-72877B98-64B2-4ACB-BC5D-098DD9EB5092 Q36470331-2AB39DAD-1B1C-4F23-807F-F0650356E5DD Q36919032-3DD998F4-7CB2-4D55-BF16-75BC510332B7 Q37086127-4C955901-3890-4CF5-9900-E79AC3BF9D06 Q37089575-9B3B0FE3-A9C8-436F-A347-DD8FBEF9E9B3 Q37641567-536F5C64-91A3-4D0D-9333-EFCBD1B176AC Q37693503-86228B78-7871-4F1D-AA33-DD592DF21C85 Q37720001-8962B0A8-3DA1-450D-8EB0-28A64C413B18 Q37720008-3F5540A3-9809-424C-979F-4DBE70F0406A Q38124762-D67CF9E3-3DC2-4508-90E7-262D3A641234 Q38234567-F523067E-1A54-46F1-9A73-D84EB920DA71 Q38246588-5E2C5FAB-48E2-4E10-903D-B1A22412A7BB Q38431602-C56AD63A-ECAA-4F0D-AD6B-C472F934BAD9 Q38508171-921E9E17-E7B3-43A6-87CF-F398346D8319 Q38724435-8CB05FC7-B312-4964-8D81-96FA7D3268AC Q38748426-29EFCADC-CE75-4217-B514-9ECE4363B12C Q38755272-9404A8AA-4110-44A1-9160-806ECF7BDD04 Q38767147-D47A42D4-552A-45F9-A608-BEFFB8D2373B

P2860

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

http://www.wikidata.org/entity/Q35313033

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

@ast

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

@en

type

label

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

@ast

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

@en

prefLabel

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

@ast

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

@en

P1433

Q35313033-43321A5F-4340-403E-BD89-D2896B3A2CD2

P1476

Q35313033-4C65E362-26EC-4371-A8FB-D7A6839BCCCF

P2093

Q35313033-0B54ED60-0607-4986-8C67-E062F2E608BC

Q35313033-0DCF6006-D25B-4A0D-8D63-5C8B6C37A32B

Q35313033-16D9165F-6D88-4E51-AB0F-3C2FC4B2AF70

Q35313033-2D6FF934-9F55-47A6-A562-C2B103707F40

Q35313033-551B5CBB-5C48-4CFA-B0EA-E6CF217F8D92

Q35313033-5D94F17E-E1C5-4CB4-9747-95EE66528779

Q35313033-79F7469D-0E2F-4494-8539-3382576D6773

Q35313033-E6A296C9-AE07-4129-97C0-7427B2140407

P2860

Q35313033-03A6BC28-8A1D-4AC5-AA48-E924DBDFD04C

Q35313033-083CD9C4-2219-4B91-AFA7-05926BA96C29

Q35313033-0AB22043-65CF-49CE-B60F-AFF6101F707E

Q35313033-13ACC894-B5FB-402B-B0FA-CE7F4E8E1803

Q35313033-1721F3B5-A1E2-4EA7-8A7A-18A824B55C44

Q35313033-1A1FBEF6-4276-4FD0-A0E4-211D25AE3770

Q35313033-218CC9A9-7891-45DA-94E0-401982D799C6

Q35313033-2CDA5606-4AE9-4A20-8DD0-794040120A25

Q35313033-2E888DA6-0714-4527-90A3-D2F869570C72

Q35313033-3448F567-7BB5-4D12-9BED-12E6A202FA99

P304

Q35313033-BA589622-912C-4FC2-AE43-70AFA03EF88D

P31

Q35313033-17BD1336-30A5-48FD-B936-C426EC51514D

P356

Q35313033-2DB67EAE-1D12-4281-B46E-C9C0E04AB8A3

P407

Q35313033-24F33229-32A4-42BD-BF3C-369D352596B0

P433

Q35313033-FB85099D-97A7-4123-ABE2-470A2F98C633

P478

Q35313033-381D4A25-659C-41F1-990B-F72EF01AACA6

P50

Q35313033-54FE2D97-D8BE-4595-B191-CBE91EA979DF

Q35313033-6310866E-B670-4BE5-8278-13B881D1FC31

P577

Q35313033-C560ADB3-3293-4CC2-B14E-69D87610BC46

P698

Q35313033-B94239F6-5910-4E57-BDAA-AE9923A2B0E0

P932

Q35313033-9A9D88DF-DFAC-4398-9A28-3B10F0722A0F

P356

JBC.M111.256644

P1433

Journal of Biological Chemistry

P1476

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration

@en

P2093

Antoine Dufour

http://www.w3.org/2001/XMLSchema#string

Ashleigh Pulkoski-Gross

http://www.w3.org/2001/XMLSchema#string

Jian Cao

http://www.w3.org/2001/XMLSchema#string

Jian Li

http://www.w3.org/2001/XMLSchema#string

Jizu Zhi

http://www.w3.org/2001/XMLSchema#string

Kevin Zarrabi

http://www.w3.org/2001/XMLSchema#string

Stanley Zucker

http://www.w3.org/2001/XMLSchema#string

Youjun Hu

http://www.w3.org/2001/XMLSchema#string

P2860

A matrix metalloproteinase expressed on the surface of invasive tumour cells

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

Structural basis of the adaptive molecular recognition by MMP9

The Dimer Interface of the Membrane Type 1 Matrix Metalloproteinase Hemopexin Domain: CRYSTAL STRUCTURE AND BIOLOGICAL FUNCTIONS

A gene-expression signature as a predictor of survival in breast cancer

Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.

Tumor cell interactions with the extracellular matrix during invasion and metastasis

New functions for the matrix metalloproteinases in cancer progression

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.

P304

33167-33177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M111.256644

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21795678

http://www.w3.org/2001/XMLSchema#string

P932

3190951

http://www.w3.org/2001/XMLSchema#string